Conventional chemotherapy or hypomethylating agents for older patients with acute myeloid leukaemia? [electronic resource]
Producer: 20140425Description: 1-9 p. digitalISSN:- 1099-1069
- Age Factors
- Aged
- Antimetabolites, Antineoplastic -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Azacitidine -- administration & dosage
- Combined Modality Therapy
- Comorbidity
- Consolidation Chemotherapy
- DNA Methylation -- drug effects
- DNA, Neoplasm -- metabolism
- DNA-Cytosine Methylases -- antagonists & inhibitors
- Decitabine
- Enzyme Inhibitors -- administration & dosage
- Hematopoietic Stem Cell Transplantation
- Humans
- Leukemia, Myeloid, Acute -- drug therapy
- Middle Aged
- Molecular Targeted Therapy
- Multicenter Studies as Topic
- Neoplasm Proteins -- antagonists & inhibitors
- Prognosis
- Randomized Controlled Trials as Topic
- Remission Induction
- Survival Rate
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.